UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 571

Sortiert nach

CheckMate-067: Raising the Bar for the Next Decade in Oncology

Journal of clinical oncology, 2022-01, Vol.40 (2), p.111-113

2022

Link zum Volltext

Verfügbarkeit prüfen

Pentostatin, Cyclophosphamide, and Rituximab Is an Active, Well-Tolerated Regimen for Patients With Previously Treated Chronic Lymphocytic Leukemia

Journal of clinical oncology, 2006-04, Vol.24 (10), p.1575-1581

2006

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial

Journal of clinical oncology, 2019-01, Vol.37 (1), p.52-60

2019

Link zum Volltext

Verfügbarkeit prüfen

Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease

Journal of clinical oncology, 2020-02, Vol.38 (6), p.576-583

2020

Link zum Volltext

Verfügbarkeit prüfen

Sequential Therapy With Fludarabine, High-Dose Cyclophosphamide, and Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia Produces High-Quality Responses: Molecular Remissions Predict for Durable Complete Responses

Journal of clinical oncology, 2009-02, Vol.27 (4), p.491-497

2009

Link zum Volltext

Verfügbarkeit prüfen

Pentostatin and Cyclophosphamide: An Effective New Regimen in Previously Treated Patients With Chronic Lymphocytic Leukemia

Journal of clinical oncology, 2003-04, Vol.21 (7), p.1278-1284

2003

Link zum Volltext

Verfügbarkeit prüfen

Fertility post immune checkpoint blockade

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.12014-12014

2023

Link zum Volltext

Verfügbarkeit prüfen

A phase 2/3 trial in progress on tebentafusp as monotherapy and in combination with pembrolizumab in HLA-A02:01+ patients with previously treated advanced non-uveal melanoma (TEBE-AM)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS9594-TPS9594

2023

Link zum Volltext

Verfügbarkeit prüfen

Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma

Journal of clinical oncology, 2013-08, Vol.31 (23), p.2927-2935

2013

Link zum Volltext

Verfügbarkeit prüfen

Functional impact of somatic mutations in early-onset (EO) versus average onset (AO) microsatellite stable (MSS) stage III colorectal cancer (CRC)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3613-3613

2022

Link zum Volltext

Verfügbarkeit prüfen

Single agent PD-1 blockade as curative-intent treatment in mismatch repair deficient locally advanced rectal cancer

Journal of clinical oncology, 2022-06, Vol.40 (17_suppl), p.LBA5-LBA5

2022

Link zum Volltext

Verfügbarkeit prüfen

PD-1 blockade alone for mismatch repair deficient (dMMR) locally advanced rectal cancer

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.16-16

2022

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of induction PD-1 blockade in subjects with locally advanced mismatch repair-deficient rectal adenocarcinoma

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.TPS4123-TPS4123

2020

Link zum Volltext

Verfügbarkeit prüfen

Microvessel density as a prognostic marker in high-risk renal cell carcinoma

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.4565-4565

2017

Link zum Volltext

Verfügbarkeit prüfen

Targeting EZH2 in acral lentiginous melanoma (ALM)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.9534-9534

2017

Link zum Volltext

Verfügbarkeit prüfen

Primary melanoma histologic subtype (HS) impacts melanoma specific survival (MSS) and response to systemic therapy

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.9577-9577

2017

Link zum Volltext

Verfügbarkeit prüfen

Biliary sclerosis and the implanted pump

Journal of clinical oncology, 1985-06, Vol.3 (6), p.884

Weiss, A J

1985

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of cancer trial eligibility criteria (with focus on non-AIDS–defining cancers) for inclusion of persons with HIV infection

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.6092-6092

2011

Link zum Volltext

Verfügbarkeit prüfen

PARP-1 inhibitor MK-4827 in combination with radiation as a treatment strategy for metastatic neuroblastoma

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.9559-9559

2011

Link zum Volltext

Verfügbarkeit prüfen

Combination therapy with voriconazole and caspofungin for fungal infections in patients with acute leukemia

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.6735-6735

2004

Link zum Volltext

Verfügbarkeit prüfen

Combination therapy with voriconazole and caspofungin for fungal infections in patients with acute leukemia

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.6735-6735

2004

Link zum Volltext

Verfügbarkeit prüfen

Pentostatin and cyclophosphamide compared to pentostatin, cyclophosphamide, and rituximab as salvage therapy for patients with chronic lymphocytic leukemia

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.6568-6568

2004

Link zum Volltext

Verfügbarkeit prüfen

Pentostatin and cyclophosphamide compared to pentostatin, cyclophosphamide, and rituximab as salvage therapy for patients with chronic lymphocytic leukemia

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.6568-6568

2004

Link zum Volltext

Verfügbarkeit prüfen

A randomized trial of cytarabine with high-dose mitoxantrone compared to a standard vincristine/prednisone-based regimen as induction therapy for adult patients with ALL

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.6516-6516

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 571

Suche als RSS-Feed

Aktive Filter

ThemaTechnology

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(571)
Mit Volltextzugriff
(564)

Publikationsform

Artikel
(571)

Sprache

Englisch
(571)
Japanisch
(29)

Erscheinungsjahr

n.n

Thema

Oncology
(149)
Humans
(146)
Life Sciences & Biomedicine
(141)
Science & Technology
(141)
Female
(117)
Male
(103)
Middle Aged
(99)
Adult
(98)
Aged
(89)
Biological And Medical Sciences
(75)
Medical Sciences
(75)
Pharmacology. Drug Treatments
(45)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(43)
Antineoplastic Agents
(40)
Aged, 80 And Over
(29)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(27)
Chemotherapy
(26)
Drug Administration Schedule
(26)
Original Reports
(24)
Tumors
(24)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

J Clin Oncol
(1)

Menü

Weitere Dienste

Einstellungen

CheckMate-067: Raising the Bar for the Next Decade in Oncology

Pentostatin, Cyclophosphamide, and Rituximab Is an Active, Well-Tolerated Regimen for Patients With Previously Treated Chronic Lymphocytic Leukemia

Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial

Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease

Sequential Therapy With Fludarabine, High-Dose Cyclophosphamide, and Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia Produces High-Quality Responses: Molecular Remissions Predict for Durable Complete Responses

Pentostatin and Cyclophosphamide: An Effective New Regimen in Previously Treated Patients With Chronic Lymphocytic Leukemia

Fertility post immune checkpoint blockade

A phase 2/3 trial in progress on tebentafusp as monotherapy and in combination with pembrolizumab in HLA-A02:01+ patients with previously treated advanced non-uveal melanoma (TEBE-AM)

Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma

Functional impact of somatic mutations in early-onset (EO) versus average onset (AO) microsatellite stable (MSS) stage III colorectal cancer (CRC)

Single agent PD-1 blockade as curative-intent treatment in mismatch repair deficient locally advanced rectal cancer

PD-1 blockade alone for mismatch repair deficient (dMMR) locally advanced rectal cancer

A phase II study of induction PD-1 blockade in subjects with locally advanced mismatch repair-deficient rectal adenocarcinoma

Microvessel density as a prognostic marker in high-risk renal cell carcinoma

Targeting EZH2 in acral lentiginous melanoma (ALM)

Primary melanoma histologic subtype (HS) impacts melanoma specific survival (MSS) and response to systemic therapy

Biliary sclerosis and the implanted pump

Evaluation of cancer trial eligibility criteria (with focus on non-AIDS–defining cancers) for inclusion of persons with HIV infection

PARP-1 inhibitor MK-4827 in combination with radiation as a treatment strategy for metastatic neuroblastoma

Combination therapy with voriconazole and caspofungin for fungal infections in patients with acute leukemia

Combination therapy with voriconazole and caspofungin for fungal infections in patients with acute leukemia

Pentostatin and cyclophosphamide compared to pentostatin, cyclophosphamide, and rituximab as salvage therapy for patients with chronic lymphocytic leukemia

Pentostatin and cyclophosphamide compared to pentostatin, cyclophosphamide, and rituximab as salvage therapy for patients with chronic lymphocytic leukemia

A randomized trial of cytarabine with high-dose mitoxantrone compared to a standard vincristine/prednisone-based regimen as induction therapy for adult patients with ALL

Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study

Aktive Filter

Suchergebnisse filtern